Clinical Trial Update: Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion [Phase 4]

View source ↗

Summary

This ClinicalTrials.gov update notes the completion of a Phase 4 trial comparing hemodilution with ranibizumab for early-onset Central Retinal Vein Occlusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Centre Hospitalier Intercommunal Creteil | Conditions: Central Retinal Vein Occlusion | Phase 4 | Status: COMPLETED